U.S. flag

An official website of the United States government

NM_000051.4(ATM):c.7088del (p.Lys2363fs) AND Hereditary cancer-predisposing syndrome

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Jan 31, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000216898.15

Allele description [Variation Report for NM_000051.4(ATM):c.7088del (p.Lys2363fs)]

NM_000051.4(ATM):c.7088del (p.Lys2363fs)

Genes:
ATM:ATM serine/threonine kinase [Gene - OMIM - HGNC]
C11orf65:chromosome 11 open reading frame 65 [Gene - HGNC]
Variant type:
Deletion
Cytogenetic location:
11q22.3
Genomic location:
Preferred name:
NM_000051.4(ATM):c.7088del (p.Lys2363fs)
HGVS:
  • NC_000011.10:g.108327757del
  • NG_009830.1:g.109926del
  • NG_054724.1:g.147079del
  • NM_000051.4:c.7088delMANE SELECT
  • NM_001330368.2:c.641-18683del
  • NM_001351110.2:c.*38+7466del
  • NM_001351834.2:c.7088del
  • NP_000042.3:p.Lys2363Argfs
  • NP_000042.3:p.Lys2363fs
  • NP_001338763.1:p.Lys2363fs
  • LRG_135t1:c.7088del
  • LRG_135:g.109926del
  • NC_000011.10:g.108327757delA
  • NC_000011.9:g.108198481del
  • NC_000011.9:g.108198484del
  • NM_000051.3:c.7088del
  • NM_000051.3:c.7088delA
Protein change:
K2363fs
Links:
dbSNP: rs876658512
NCBI 1000 Genomes Browser:
rs876658512
Molecular consequence:
  • NM_000051.4:c.7088del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001351834.2:c.7088del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001330368.2:c.641-18683del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001351110.2:c.*38+7466del - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000273859Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Pathogenic
(Jan 31, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link,

SCV001357927Color Diagnostics, LLC DBA Color Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jan 15, 2020)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Two Novel Mutations Associated With Ataxia-Telangiectasia Identified Using an Ion AmpliSeq Inherited Disease Panel.

Kuznetsova MV, Trofimov DY, Shubina ES, Kochetkova TO, Karetnikova NA, Barkov IY, Bakharev VA, Gusev OA, Sukhikh GT.

Front Neurol. 2017;8:570. doi: 10.3389/fneur.2017.00570.

PubMed [citation]
PMID:
29163336
PMCID:
PMC5670107

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Ambry Genetics, SCV000273859.7

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The c.7088delA pathogenic mutation, located in coding exon 47 of the ATM gene, results from a deletion of one nucleotide at nucleotide position 7088, causing a translational frameshift with a predicted alternate stop codon (p.K2363Rfs*3). This alteration was identified in the homozygous state in two siblings with ataxia-telangiectasia (Kuznetsova MV et al. Front Neurol. 2017 Oct;8:570). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Color Diagnostics, LLC DBA Color Health, SCV001357927.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This variant deletes 1 nucleotide in exon 48 of the ATM gene, creating a frameshift and premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Loss of ATM function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024